US Stock MarketDetailed Quotes

ETON Eton Pharmaceutical

Watchlist
  • 12.570
  • +0.290+2.36%
Close Dec 20 16:00 ET
  • 12.570
  • 0.0000.00%
Post 20:01 ET
327.47MMarket Cap-59.86P/E (TTM)

About Eton Pharmaceutical Company

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Company Profile

SymbolETON
Company NameEton Pharmaceutical
Listing DateNov 13, 2018
Issue Price6.00
Founded2017
MarketNASDAQ
Employees30
Fiscal Year Ends12-31
Address21925 West Field Parkway,Suite 235
CityDeer Park
ProvinceIllinois
CountryUnited States of America
Zip Code60010-7278
Phone1-847-787-7361
Websitehttp://www.etonpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Sean E. Brynjelsen
  • President, Chief Executive Officer and Director
  • 1.75M
  • James R. Gruber
  • Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary
  • 785.14K
  • David C. Krempa
  • Chief Business Officer
  • 719.08K
  • Dr. Norbert G. Riedel,PhD
  • Chairman of the Board
  • 155.50K
  • Paul Victor Maier
  • Independent Director
  • 129.50K
  • Charles J. Casamento
  • Independent Director
  • 126.90K
  • Jennifer McKie Adams
  • Independent Director
  • 119.10K
Heat List
US
Overall
Symbol
Price
% Chg

No Data